Global Amantadine HCl Oral Market Insights, Forecast to 2025

Publisher Name :
Date: 19-Jun-2019
No. of pages: 123
Inquire Before Buying

Amantadine is a medication that has U.S. Food and Drug Administration approval for use both as an antiviral and an antiparkinsonian medication.

The global Amantadine HCl Oral market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Amantadine HCl Oral market based on company, product type, end user and key regions.

This report studies the global market size of Amantadine HCl Oral in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Amantadine HCl Oral in these regions.

This research report categorizes the global Amantadine HCl Oral market by top players/brands, region, type and end user. This report also studies the global Amantadine HCl Oral market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Zydus Pharmaceuticals

- Mylan

- Teva

- Vertical Pharmaceuticals

- Adamas Pharmaceuticals

- Upsher-Smith

- Sandoz

- Mikart Pharmaceuticals

- Pharmaceutical Associates, Inc. (PAI)

- Wockhardt Bio AG

- CMP Pharma

- Bionpharma

- Graviti Pharma

- Alembic Pharmaceuticals

- Strides Pharma

- Heritage Pharmaceuticals

Market size by Product

- Tablet

- Capsules

- Syrup

Market size by End User

- Parkinson's disease

- Influenza

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Amantadine HCl Oral market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Amantadine HCl Oral market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Amantadine HCl Oral companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Amantadine HCl Oral submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Amantadine HCl Oral are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Amantadine HCl Oral market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Amantadine HCl Oral Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Amantadine HCl Oral Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Amantadine HCl Oral Market Size Growth Rate by Product
1.4.2 Tablet
1.4.3 Capsules
1.4.4 Syrup
1.5 Market by End User
1.5.1 Global Amantadine HCl Oral Market Size Growth Rate by End User
1.5.2 Parkinson's disease
1.5.3 Influenza
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Amantadine HCl Oral Market Size
2.1.1 Global Amantadine HCl Oral Revenue 2014-2025
2.1.2 Global Amantadine HCl Oral Sales 2014-2025
2.2 Amantadine HCl Oral Growth Rate by Regions
2.2.1 Global Amantadine HCl Oral Sales by Regions
2.2.2 Global Amantadine HCl Oral Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Amantadine HCl Oral Sales by Manufacturers
3.1.1 Amantadine HCl Oral Sales by Manufacturers
3.1.2 Amantadine HCl Oral Sales Market Share by Manufacturers
3.1.3 Global Amantadine HCl Oral Market Concentration Ratio (CR5 and HHI)
3.2 Amantadine HCl Oral Revenue by Manufacturers
3.2.1 Amantadine HCl Oral Revenue by Manufacturers (2014-2019)
3.2.2 Amantadine HCl Oral Revenue Share by Manufacturers (2014-2019)
3.3 Amantadine HCl Oral Price by Manufacturers
3.4 Amantadine HCl Oral Manufacturing Base Distribution, Product Types
3.4.1 Amantadine HCl Oral Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Amantadine HCl Oral Product Type
3.4.3 Date of International Manufacturers Enter into Amantadine HCl Oral Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Amantadine HCl Oral Sales by Product
4.2 Global Amantadine HCl Oral Revenue by Product
4.3 Amantadine HCl Oral Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Amantadine HCl Oral Breakdown Data by End User
6 North America
6.1 North America Amantadine HCl Oral by Countries
6.1.1 North America Amantadine HCl Oral Sales by Countries
6.1.2 North America Amantadine HCl Oral Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Amantadine HCl Oral by Product
6.3 North America Amantadine HCl Oral by End User
7 Europe
7.1 Europe Amantadine HCl Oral by Countries
7.1.1 Europe Amantadine HCl Oral Sales by Countries
7.1.2 Europe Amantadine HCl Oral Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Amantadine HCl Oral by Product
7.3 Europe Amantadine HCl Oral by End User
8 Asia Pacific
8.1 Asia Pacific Amantadine HCl Oral by Countries
8.1.1 Asia Pacific Amantadine HCl Oral Sales by Countries
8.1.2 Asia Pacific Amantadine HCl Oral Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Amantadine HCl Oral by Product
8.3 Asia Pacific Amantadine HCl Oral by End User
9 Central & South America
9.1 Central & South America Amantadine HCl Oral by Countries
9.1.1 Central & South America Amantadine HCl Oral Sales by Countries
9.1.2 Central & South America Amantadine HCl Oral Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Amantadine HCl Oral by Product
9.3 Central & South America Amantadine HCl Oral by End User
10 Middle East and Africa
10.1 Middle East and Africa Amantadine HCl Oral by Countries
10.1.1 Middle East and Africa Amantadine HCl Oral Sales by Countries
10.1.2 Middle East and Africa Amantadine HCl Oral Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Amantadine HCl Oral by Product
10.3 Middle East and Africa Amantadine HCl Oral by End User
11 Company Profiles
11.1 Zydus Pharmaceuticals
11.1.1 Zydus Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Zydus Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Zydus Pharmaceuticals Amantadine HCl Oral Products Offered
11.1.5 Zydus Pharmaceuticals Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Company Business Overview
11.2.3 Mylan Amantadine HCl Oral Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Mylan Amantadine HCl Oral Products Offered
11.2.5 Mylan Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Company Business Overview
11.3.3 Teva Amantadine HCl Oral Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Teva Amantadine HCl Oral Products Offered
11.3.5 Teva Recent Development
11.4 Vertical Pharmaceuticals
11.4.1 Vertical Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Vertical Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Vertical Pharmaceuticals Amantadine HCl Oral Products Offered
11.4.5 Vertical Pharmaceuticals Recent Development
11.5 Adamas Pharmaceuticals
11.5.1 Adamas Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Adamas Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Adamas Pharmaceuticals Amantadine HCl Oral Products Offered
11.5.5 Adamas Pharmaceuticals Recent Development
11.6 Upsher-Smith
11.6.1 Upsher-Smith Company Details
11.6.2 Company Business Overview
11.6.3 Upsher-Smith Amantadine HCl Oral Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Upsher-Smith Amantadine HCl Oral Products Offered
11.6.5 Upsher-Smith Recent Development
11.7 Sandoz
11.7.1 Sandoz Company Details
11.7.2 Company Business Overview
11.7.3 Sandoz Amantadine HCl Oral Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Sandoz Amantadine HCl Oral Products Offered
11.7.5 Sandoz Recent Development
11.8 Mikart Pharmaceuticals
11.8.1 Mikart Pharmaceuticals Company Details
11.8.2 Company Business Overview
11.8.3 Mikart Pharmaceuticals Amantadine HCl Oral Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Mikart Pharmaceuticals Amantadine HCl Oral Products Offered
11.8.5 Mikart Pharmaceuticals Recent Development
11.9 Pharmaceutical Associates, Inc. (PAI)
11.9.1 Pharmaceutical Associates, Inc. (PAI) Company Details
11.9.2 Company Business Overview
11.9.3 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Products Offered
11.9.5 Pharmaceutical Associates, Inc. (PAI) Recent Development
11.10 Wockhardt Bio AG
11.10.1 Wockhardt Bio AG Company Details
11.10.2 Company Business Overview
11.10.3 Wockhardt Bio AG Amantadine HCl Oral Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Wockhardt Bio AG Amantadine HCl Oral Products Offered
11.10.5 Wockhardt Bio AG Recent Development
11.11 CMP Pharma
11.12 Bionpharma
11.13 Graviti Pharma
11.14 Alembic Pharmaceuticals
11.15 Strides Pharma
11.16 Heritage Pharmaceuticals
12 Future Forecast
12.1 Amantadine HCl Oral Market Forecast by Regions
12.1.1 Global Amantadine HCl Oral Sales Forecast by Regions 2019-2025
12.1.2 Global Amantadine HCl Oral Revenue Forecast by Regions 2019-2025
12.2 Amantadine HCl Oral Market Forecast by Product
12.2.1 Global Amantadine HCl Oral Sales Forecast by Product 2019-2025
12.2.2 Global Amantadine HCl Oral Revenue Forecast by Product 2019-2025
12.3 Amantadine HCl Oral Market Forecast by End User
12.4 North America Amantadine HCl Oral Forecast
12.5 Europe Amantadine HCl Oral Forecast
12.6 Asia Pacific Amantadine HCl Oral Forecast
12.7 Central & South America Amantadine HCl Oral Forecast
12.8 Middle East and Africa Amantadine HCl Oral Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Amantadine HCl Oral Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Amantadine HCl Oral Product Picture
Table Amantadine HCl Oral Market Segments
Table Key Manufacturers Amantadine HCl Oral Covered
Table Global Amantadine HCl Oral Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Amantadine HCl Oral Sales Market Share by Product 2014-2025
Figure Tablet Product Picture
Table Major Manufacturers of Tablet
Figure Capsules Product Picture
Table Major Manufacturers of Capsules
Figure Syrup Product Picture
Table Major Manufacturers of Syrup
Table Global Amantadine HCl Oral Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Parkinson's disease
Figure Influenza
Figure Amantadine HCl Oral Report Years Considered
Figure Global Amantadine HCl Oral Market Size 2014-2025 (Million US$)
Figure Global Amantadine HCl Oral Sales 2014-2025 (K Units)
Table Global Amantadine HCl Oral Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Amantadine HCl Oral Sales by Regions 2014-2019 (K Units)
Table Global Amantadine HCl Oral Sales Market Share by Regions 2014-2019
Figure Global Amantadine HCl Oral Sales Market Share by Regions 2014-2019
Figure 2018 Global Amantadine HCl Oral Sales Market Share by Regions
Table Global Amantadine HCl Oral Revenue by Regions 2014-2019 (Million US$)
Table Global Amantadine HCl Oral Revenue Market Share by Regions 2014-2019
Figure Global Amantadine HCl Oral Revenue Market Share by Regions 2014-2019
Figure 2018 Global Amantadine HCl Oral Revenue Market Share by Regions
Table Global Amantadine HCl Oral Sales by Manufacturers (2014-2019) (K Units)
Table Global Amantadine HCl Oral Sales Share by Manufacturers (2014-2019)
Figure Global Amantadine HCl Oral Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Amantadine HCl Oral Revenue by Manufacturers (2014-2019) (Million USD)
Table Amantadine HCl Oral Revenue Share by Manufacturers (2014-2019)
Figure Amantadine HCl Oral Value Share by Manufacturers in 2018
Table Key Manufacturers Amantadine HCl Oral Price (2014-2019) (USD/Unit)
Table Amantadine HCl Oral Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Amantadine HCl Oral Product Type
Table Date of International Manufacturers Enter into Amantadine HCl Oral Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Amantadine HCl Oral Sales by Product (2014-2019) (K Units)
Table Global Amantadine HCl Oral Sales Share by Product (2014-2019)
Figure Global Amantadine HCl Oral Sales Market Share by Product (2014-2019)
Figure Global Amantadine HCl Oral Sales Market Share by Product in 2018
Table Global Amantadine HCl Oral Revenue by Product (2014-2019) (Million US$)
Table Global Amantadine HCl Oral Revenue Share by Product (2014-2019)
Figure Global Amantadine HCl Oral Revenue Market Share by Product (2014-2019)
Figure Global Amantadine HCl Oral Revenue Market Share by Product in 2018
Table Amantadine HCl Oral Price by Product 2014-2019 (USD/Unit)
Table Global Amantadine HCl Oral Sales by End User (2014-2019) (K Units)
Table Global Amantadine HCl Oral Sales Share by End User (2014-2019)
Figure Global Sales Amantadine HCl Oral Market Share by End User (2014-2019)
Figure Global Sales Amantadine HCl Oral Market Share by End User in 2018
Figure North America Amantadine HCl Oral Sales Growth Rate 2014-2019 (K Units)
Figure North America Amantadine HCl Oral Revenue Growth Rate 2014-2019 (Million US$)
Table North America Amantadine HCl Oral Sales by Countries (2014-2019) (K Units)
Table North America Amantadine HCl Oral Sales Market Share by Countries (2014-2019)
Figure 2018 North America Amantadine HCl Oral Sales Market Share by Countries
Table North America Amantadine HCl Oral Revenue by Countries (2014-2019) (Million US$)
Table North America Amantadine HCl Oral Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Amantadine HCl Oral Revenue Market Share by Countries
Figure United States Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure United States Amantadine HCl Oral Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Canada Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Table North America Amantadine HCl Oral Sales by Product (2014-2019) (K Units)
Table North America Amantadine HCl Oral Sales Market Share by Product (2014-2019)
Figure 2018 North America Amantadine HCl Oral Market Share by Product
Table North America Amantadine HCl Oral Sales by End User (2014-2019) (K Units)
Table North America Amantadine HCl Oral Sales Market Share by End User (2014-2019)
Figure 2018 North America Amantadine HCl Oral Market Share by End User
Figure Europe Amantadine HCl Oral Sales Growth Rate 2014-2019 (K Units)
Figure Europe Amantadine HCl Oral Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Amantadine HCl Oral Sales by Countries (2014-2019) (K Units)
Table Europe Amantadine HCl Oral Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Amantadine HCl Oral Sales Market Share by Countries
Table Europe Amantadine HCl Oral Revenue by Countries (2014-2019) (Million US$)
Table Europe Amantadine HCl Oral Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Amantadine HCl Oral Revenue Market Share by Countries
Figure Germany Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Germany Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure France Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure France Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure UK Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Italy Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Russia Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Amantadine HCl Oral Sales by Product (2014-2019) (K Units)
Table Europe Amantadine HCl Oral Sales Market Share by Product (2014-2019)
Figure 2018 Europe Amantadine HCl Oral Market Share by Product
Table Europe Amantadine HCl Oral Sales by End User (2014-2019) (K Units)
Table Europe Amantadine HCl Oral Sales Market Share by End User (2014-2019)
Figure 2018 Europe Amantadine HCl Oral Market Share by End User
Figure Asia Pacific Amantadine HCl Oral Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Amantadine HCl Oral Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Amantadine HCl Oral Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Amantadine HCl Oral Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Amantadine HCl Oral Sales Market Share by Countries
Table Asia Pacific Amantadine HCl Oral Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Amantadine HCl Oral Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Amantadine HCl Oral Revenue Market Share by Countries
Figure China Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure China Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Japan Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Korea Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure India Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure India Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Australia Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Amantadine HCl Oral Sales by Product (2014-2019) (K Units)
Table Asia Pacific Amantadine HCl Oral Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Amantadine HCl Oral Market Share by Product
Table Asia Pacific Amantadine HCl Oral Sales by End User (2014-2019) (K Units)
Table Asia Pacific Amantadine HCl Oral Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Amantadine HCl Oral Market Share by End User
Figure Central & South America Amantadine HCl Oral Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Amantadine HCl Oral Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Amantadine HCl Oral Sales by Countries (2014-2019) (K Units)
Table Central & South America Amantadine HCl Oral Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Amantadine HCl Oral Sales Market Share by Countries
Table Central & South America Amantadine HCl Oral Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Amantadine HCl Oral Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Amantadine HCl Oral Revenue Market Share by Countries
Figure Brazil Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Amantadine HCl Oral Sales by Product (2014-2019) (K Units)
Table Central & South America Amantadine HCl Oral Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Amantadine HCl Oral Market Share by Product
Table Central & South America Amantadine HCl Oral Sales by End User (2014-2019) (K Units)
Table Central & South America Amantadine HCl Oral Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Amantadine HCl Oral Market Share by End User
Figure Middle East and Africa Amantadine HCl Oral Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Amantadine HCl Oral Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Amantadine HCl Oral Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Amantadine HCl Oral Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Amantadine HCl Oral Sales Market Share by Countries
Table Middle East and Africa Amantadine HCl Oral Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Amantadine HCl Oral Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Amantadine HCl Oral Revenue Market Share by Countries
Figure GCC Countries Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Amantadine HCl Oral Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Amantadine HCl Oral Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Amantadine HCl Oral Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Amantadine HCl Oral Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Amantadine HCl Oral Market Share by Product
Table Middle East and Africa Amantadine HCl Oral Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Amantadine HCl Oral Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Amantadine HCl Oral Market Share by End User
Table Zydus Pharmaceuticals Company Details
Table Zydus Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zydus Pharmaceuticals Recent Development
Table Mylan Company Details
Table Mylan Amantadine HCl Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mylan Recent Development
Table Teva Company Details
Table Teva Amantadine HCl Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Recent Development
Table Vertical Pharmaceuticals Company Details
Table Vertical Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Vertical Pharmaceuticals Recent Development
Table Adamas Pharmaceuticals Company Details
Table Adamas Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Adamas Pharmaceuticals Recent Development
Table Upsher-Smith Company Details
Table Upsher-Smith Amantadine HCl Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Upsher-Smith Recent Development
Table Sandoz Company Details
Table Sandoz Amantadine HCl Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sandoz Recent Development
Table Mikart Pharmaceuticals Company Details
Table Mikart Pharmaceuticals Amantadine HCl Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mikart Pharmaceuticals Recent Development
Table Pharmaceutical Associates, Inc. (PAI) Company Details
Table Pharmaceutical Associates, Inc. (PAI) Amantadine HCl Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pharmaceutical Associates, Inc. (PAI) Recent Development
Table Wockhardt Bio AG Company Details
Table Wockhardt Bio AG Amantadine HCl Oral Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Wockhardt Bio AG Recent Development
Table CMP Pharma Company Details
Table Bionpharma Company Details
Table Graviti Pharma Company Details
Table Alembic Pharmaceuticals Company Details
Table Strides Pharma Company Details
Table Heritage Pharmaceuticals Company Details
Table Global Amantadine HCl Oral Sales Forecast by Regions 2019-2025 (K Units)
Table Global Amantadine HCl Oral Sales Market Share Forecast by Regions 2019-2025
Table Global Amantadine HCl Oral Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Amantadine HCl Oral Revenue Market Share Forecast by Regions 2019-2025
Table Global Amantadine HCl Oral Sales Forecast by Product 2019-2025 (K Units)
Table Global Amantadine HCl Oral Sales Market Share Forecast by Product 2019-2025
Table Global Amantadine HCl Oral Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Amantadine HCl Oral Revenue Market Share Forecast by Product 2019-2025
Table Global Amantadine HCl Oral Sales Forecast by End User 2019-2025 (K Units)
Table Global Amantadine HCl Oral Sales Market Share Forecast by End User 2019-2025
Figure North America Amantadine HCl Oral Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Amantadine HCl Oral Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Amantadine HCl Oral Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Amantadine HCl Oral Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Amantadine HCl Oral Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Amantadine HCl Oral Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Amantadine HCl Oral Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Amantadine HCl Oral Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Amantadine HCl Oral Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Amantadine HCl Oral Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Amantadine HCl Oral Value Chain
Table Amantadine HCl Oral Customers List
Table Amantadine HCl Oral Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs